Aerovate Therapeutics
Why Robinhood?
You can watch AVTE and buy or sell other stocks, ETFs, and their options commission-free!About AVTE
Jade Biosciences, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension.
AVTE Key Statistics
Stock Snapshot
The current Aerovate Therapeutics(AVTE) stock price is $9.80, with a market capitalization of 483.3M. The stock trades at a price-to-earnings (P/E) ratio of -4.47.
On 2026-05-01, Aerovate Therapeutics(AVTE) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 805.28K.
Over the past 52 weeks, Aerovate Therapeutics(AVTE) stock has traded between a high of $28.00 and a low of $6.57.
Over the past 52 weeks, Aerovate Therapeutics(AVTE) stock has traded between a high of $28.00 and a low of $6.57.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.